BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25452954)

  • 1. The challenges of treating laryngeal carcinoma in jos, Nigeria.
    Adoga A; Ma'an E
    J West Afr Coll Surg; 2011 Apr; 1(2):63-75. PubMed ID: 25452954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laryngeal carcinoma: our experience at Obafemi Awolowo University Teaching Hospital complex, Ile-Ife, Nigeria.
    Amusa YB; Badmus TA; Olabanji JK; Oyebamiji EO
    Cent Afr J Med; 2009; 55(9-12):54-8. PubMed ID: 21977845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of pectoralis major myocutanuos flap in salvage laryngeal surgery for prophylaxis of pharyngocutaneuos fistula and reconstruction of skin defect.
    Mebeed AH; Hussein HA; Saber TKh; Zohairy MA; Lotayef M
    J Egypt Natl Canc Inst; 2009 Mar; 21(1):23-32. PubMed ID: 20601968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-operative complications of salvage total laryngectomy forpost-radiotherapy recurrent laryngeal cancer using pectoralis major myocutaneous flaps.
    Okamoto I; Tsukahara K; Shimizu A; Sato H
    Acta Otolaryngol; 2019 Feb; 139(2):167-171. PubMed ID: 30794035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
    Varghese BT; Sebastian P; Mathew A
    Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stomal recurrence post laryngectomy in University College Hospital, Ibadan.
    Onakoya PA; Nwaorgu OG; Kokong DD; Adeosun AA; Ayodele KJ
    Afr J Med Med Sci; 2004 Mar; 33(1):65-8. PubMed ID: 15490797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing tumour relapse after total laryngectomy.
    Nikolaou A; Markou K; Petridis D; Vlachtsis K; Nalbantian M; Daniilidis L
    B-ENT; 2005; 1(1):1-10. PubMed ID: 15999669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of brain tumours at Jos University Teaching Hospital, Nigeria.
    Igun GO
    East Afr Med J; 2001 Mar; 78(3):148-51. PubMed ID: 12002056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant tumors of the larynx: Clinicopathologic profile and implication for late disease presentation.
    Fasunla AJ; Ogundoyin OA; Onakoya PA; Nwaorgu OG
    Niger Med J; 2016; 57(5):280-285. PubMed ID: 27833247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation and survival in patients with hematologic malignancies in Jos, Nigeria: A retrospective cohort analysis.
    Egesie OJ; Agaba PA; Silas OA; Achenbach C; Zoakah A; Agbaji OO; Madaki JA; Okeke EN; Hou L; Sagay AS; Murphy R
    J Med Trop; 2018; 20(1):49-56. PubMed ID: 29963503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male breast malignancy in Jos University Teaching Hospital.
    Kidmas AT; Ugwu BT; Manasseh AN; Iya D; Opaluwa AS
    West Afr J Med; 2005; 24(1):36-40. PubMed ID: 15909708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fistula rates after salvage laryngectomy: comparing pectoralis myofascial and myocutaneous flaps.
    Khan NA; Medina JE; Sanclement JA; Krempl GA
    Laryngoscope; 2014 Jul; 124(7):1615-7. PubMed ID: 24122869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydatidiform mole in Jos, Nigeria.
    Ocheke AN; Musa J; Uamai AO
    Niger Med J; 2011 Oct; 52(4):223-6. PubMed ID: 22529502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total laryngectomy for laryngeal cancer in a nigerian tertiary health center: prognosis and outcome.
    Iseh K
    J Surg Tech Case Rep; 2011 Jan; 3(1):23-30. PubMed ID: 22022650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of laryngeal cancer in an ENT Service in subSaharan Africa].
    Mvouni Oyono S; Njock R; Fouda A; Moune A; Bengono G
    Sante; 2006; 16(2):109-12. PubMed ID: 17116634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pectoralis major myofascial interposition flap prevents postoperative pharyngocutaneous fistula in salvage total laryngectomy.
    Anschütz L; Nisa L; Elicin O; Bojaxhiu B; Caversaccio M; Giger R
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3943-3949. PubMed ID: 27107580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of a pectoralis major myocutaneous flap in preventing salivary fistulae after salvage total laryngectomy.
    Sousa AA; Castro SM; Porcaro-Salles JM; Soares JM; de Moraes GM; Carvalho JR; Silva GS
    Braz J Otorhinolaryngol; 2012; 78(4):103-7. PubMed ID: 22936145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.